Karl Schmieder Biotech Storytelling, Strategy, and Commercialization Stories in Life Sciences

Most biotech founders are deeply fluent in their science. Fewer are fluent in the story that moves their market. In this episode of Stories in Life Sciences by MedAxis AI, Christopher Wilson sits down with Karl Schmieder, Founder of MessagingLab and co-host of the Grow Everything podcast, to explore how strategic communication and narrative shape the path from discovery to commercialization.Karl's background spans biochemistry and creative writing, a combination that led him to build a practice helping biotech innovators translate complex science into messaging that drives adoption. He works with founders at every stage of the product lifecycle to sharpen strategy, clarify value, and build narratives that accelerate market entry.In this episode of Stories in Life Sciences, we cover:Why biotech founders struggle to communicate their value to non-scientific audiencesHow to tailor messaging for each audience across the product lifecycleWhy niche focus and ecosystem thinking are essential for biotech commercializationThe role of AI as a strategic collaborator in research, marketing, and go-to-market planningHow Karl's path from biochemistry to creative writing shaped his approach to biotech strategyThe most common communication pitfalls as companies move from discovery to marketWhy the fastest-growing biotech companies invest in strategic storytelling earlyWho this is for: biotech and medtech founders, commercialization leads, and life sciences marketers who want to understand how strategic communication drives market adoption.Guest: Karl SchmiederCEO and Founder, MessagingLab https://www.messaginglab.com https://www.linkedin.com/company/messaginglabHost:Christopher Wilson, Founder, MedAxis AIwww.medaxisai.orghttps://www.linkedin.com/in/christopher-wilson-medaxisai https://www.linkedin.com/company/medaxisaiFollow Stories in Life Sciences on Spotify, Apple Podcasts, and YouTube for new episodes.